Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis

Journal of Microbiology

Volumn 54, Issue 3, 2016, Pages 265-276

  Woods, Jon P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

dimorphism; fungus; virulence

Indexed keywords

ANIMAL; CYTOLOGY; GENETICS; HISTOPLASMA; HISTOPLASMOSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPROMISED PATIENT; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ANIMALS; HISTOPLASMA; HISTOPLASMOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; VIRULENCE;

EID: 84959247989     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-016-6044-5     Document Type: Review

References (133)

1. Aravalli, R.N., Hu, S., Woods, J.P., and Lokensgard, J.R. 2008. Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling. J. Neuroinflammation5, 30.
2. Barber, M.F. and Eide, N.C. 2015. Buried treasure: evolutionary perspectives on microbial iron piracy. Trends Genet.31, 627–636.
3. Batanghari, J.W., Deepe, G.S., Cera, E.D., and Goldman, W.E. 1998. Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol. Microbiol.27, 531–539.
4. Batanghari, J.W. and Goldman, W.E. 1997. Calcium dependence and binding in cultures of Histoplasma capsulatum. Infect. Immun.65, 5257–5261.
5. Beck, M.R., DeKoster, G.T., Cistola, D.P., and Goldman, W.E. 2009. NMR structure of a fungal virulence factor reveals structural homology with mammalian saposin B. Mol. Microbiol.72, 344–353.
6. Beck, M.R., DeKoster, G.T., Hambly, D.M., Gross, M.L., Cistola, D.P., and Goldman, W.E. 2008. Structural features responsible for the biological stability of Histoplasma’s virulence factor CBP. Biochemistry47, 4427–4438.
7. Beyhan, S., Gutierrez, M., Voorhies, M., and Sil, A. 2013. A temperature-responsive network links cell shape and virulence traits in a primary fungal pathogen. PLoS Biol.11, e1001614.
8. Bohse, M.L. and Woods, J.P. 2005. Surface localization of the Yps3p protein of Histoplasma capsulatum. Eukaryot. Cell4, 685–693.
9. Bohse, M.L. and Woods, J.P. 2007a. Expression and interstrain variability of the YPS3 gene of Histoplasma capsulatum. Eukaryot. Cell6, 609–615.
10. Bohse, M.L. and Woods, J.P. 2007b. RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects. Infect. Immun.75, 2811–2817.
11. Boyce, K.J. and Andrianopoulos, A. 2015. Fungal dimorphism: the switch from hyphae to yeast is a specialized morphogenetic adaptation allowing colonization of a host. FEMS Microbiol. Rev.39, 797–811.
12. Brandhorst, T. and Klein, B. 2000. Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin. J. Biol. Chem.275, 7925–7934.
13. Brandhorst, T., Wuthrich, M., Finkel-Jimenez, B., and Klein, B. 2003. A C-terminal EGF-like domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis. Mol. Microbiol.48, 53–65.
14. Brandhorst, T.T., Wuthrich, M., Warner, T., and Klein, B. 1999. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J. Exp. Med.189, 1207–1216.
15. Brummer, E. and Kamei, K. 2014. Histoplasma capsulatum: master evader of innate immunity. Med. Mycol. J.55, E57–E62.
16. Brummer, E., Kurita, N., Yoshida, S., Nishimura, K., and Miyaji, M. 1991. Killing of Histoplasma capsulatum by γ-interferon-activated human monocyte-derived macrophages: evidence for a superoxide anion-dependent mechanism. J. Med. Microbiol.35, 29–34.
17. Brummer, E. and Stevens, D.A. 1995. Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum. Clin. Exp. Immunol.102, 65–70.
18. Burt, W.R. 1982. Identification of coprogen B and its breakdown products from Histoplasma capsulatum. Infect. Immun.35, 990–996.
19. Burt, W.R., Underwood, A.L., and Appleton, G.L. 1981. Hydroxamic acid from Histoplasma capsulatum that displays growth factor activity. Appl. Environ. Microbiol.42, 560–563.
20. Cain, C.W., Lohse, M.B., Homann, O.R., Sil, A., and Johnson, A.D. 2012. A conserved transcriptional regulator governs fungal morphology in widely diverged species. Genetics190, 511–521.
21. Cano, M.V.C. and Hajjeh, R.A. 2001. The epidemiology of histoplasmosis: a review. Sem. Resp. Infect.16, 109–118.
22. Chao, L.Y., Marletta, M.A., and Rine, J. 2008. Sre1, an iron-modulated GATA DNA-binding protein of iron-uptake genes in the fungal pathogen Histoplasma capsulatum. Biochemistry47, 7274–7283.
23. Chao, L.Y., Rine, J., and Marletta, M.A. 2008. Spectroscopic and kinetic studies of Nor1, a cytochrome P450 nitric oxide reductase from the fungal pathogen Histoplasma capsulatum. Arch. Biochem. Biophys.480, 132–137.
24. Cooper, K.G. and Woods, J.P. 2009. Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum. Infect. Immun.77, 2447–2454.
25. Cooper, K.G., Zarnowski, R., and Woods, J.P. 2009. Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P. PLoS One4, e5281.
26. Darling, S.T. 1906. A protozoan general infection producing pseudotubercles in the lungs and focal necroses in the liver, spleen and lymphnodes. JAMA46, 1283–1285.
27. Deepe, G.S. 2000. Immune response to early and late Histoplasma capsulatum infections. Curr. Opin. Microbiol.3, 359–362.
28. Deepe, G.S. and Buesing, W.R. 2012. Deciphering the pathways of death of Histoplasma capsulatum-infected macrophages: implications for the immunopathogenesis of early infection. J. Immunol.188, 334–344.
29. Deepe, G.S. and Seder, R.A. 1998. Molecular and cellular determinants of immunity to Histoplasma capsulatum. Res. Immunol.149, 397–406.
30. Desai, G., Nassar, F., Brummer, E., and Stevens, D.A. 1995. Killing of Histoplasma capsulatum by macrophage colony stimulating factor-treated human monocyte-derived macrophages: role for reactive oxygen intermediates. J. Med. Microbiol.43, 224–229.
31. Drummond, R.A. and Brown, G.D. 2011. The role of Dectin-1 in the host defence against fungal infections. Curr. Opin. Microbiol.14, 392–399.
32. Edwards, J.A., Alore, E.A., and Rappleye, C.A. 2011. The yeastphase virulence requirement for a-glucan synthase differs among Histoplasma capsulatum chemotypes. Eukaryot. Cell10, 87–97.
33. Edwards, J.A., Chen, C., Kemski, M.M., Hu, J., Mitchell, T.K., and Rappleye, C.A. 2013. Histoplasma yeast and mycelial transcriptomes reveal pathogenic-phase and lineage-specific gene expression profiles. BMC Genomics14, 695.
34. Edwards, J.A. and Rappleye, C.A. 2011. Histoplasma mechanisms of pathogenesis–one portfolio doesn’t fit all. FEMS Microbiol. Lett.324, 1–9.
35. Edwards, J.A., Zemska, O., and Rappleye, C.A. 2011. Discovery of a role for Hsp82 in Histoplasma virulence through a quantitative screen for macrophage lethality. Infect. Immun.79, 3348–3357.
36. Eissenberg, L.G. and Goldman, W.E. 1987. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect. Immun.55, 29–34.
37. Eissenberg, L.G., West, J.L., Woods, J.P., and Goldman, W.E. 1991. Infection of P388D1 macrophages and respiratory epithelial cells by Histoplasma capsulatum: Selection of avirulent variants and their potential role in persistent histoplasmosis. Infect. Immun.59, 1639–1646.
38. Finkel-Jimenez, B., Wuthrich, M., Brandhorst, T., and Klein, B.S. 2001. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J. Immunol.166, 2665–2673.
39. Finkel-Jimenez, B., Wuthrich, M., and Klein, B.S. 2002. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J. Immunol.168, 5746–5755.
40. Fisher, K.L., Deepe, G.S., and Woods, J.P. 1999. Histoplasma capsulatum strain variation in both H antigen production and β-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid. Infect. Immun.67, 3312–3316.
41. Fisher, K.L. and Woods, J.P. 2000. Determination of β-glucosidase enzymatic function of the Histoplasma capsulatum H antigen using a native expression system. Gene247, 191–197.
42. Garfoot, A.L. and Rappleye, C.A. 2015. Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis. FEBS J.2015, 13389.
43. Garfoot, A.L., Zemska, O., and Rappleye, C.A. 2014. Histoplasma capsulatum depends on de novo vitamin biosynthesis for intraphagosomal proliferation. Infect. Immun.82, 393–404.
44. Gebhart, D., Bahrami, A.K., and Sil, A. 2006. Identification of a copper- inducible promoter for use in ectopic expression in the fungal pathogen Histoplasma capsulatum. Eukaryot. Cell5, 935–944.
45. Gilmore, S.A., Naseem, S., Konopka, J.B., and Sil, A. 2013. N-acetylglucosamine (GlcNAc) triggers a rapid, temperature-responsive morphogenetic program in thermally dimorphic fungi. PLoS Genet.9, e1003799.
46. Gilmore, S.A., Voorhies, M., Gebhart, D., and Sil, A. 2015. Genomewide reprogramming of transcript architecture by temperature specifies the developmental states of the human pathogen Histoplasma. PLoS Genet.11, e1005395.
47. Guimaraes, A.J., de Cerqueira, M.D., and Nosanchuk, J.D. 2011. Surface architecture of Histoplasma capsulatum. Front. Microbiol.2, 225.
48. Guimaraes, A.J., Hamilton, A.J., de Guedes, H.L., Nosanchuk, J.D., and Zancope-Oliviera, R.M. 2008. Biological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum. PLoS One3, e3449.
49. Hamilton, A.J., Bartholomew, M.A., Figueroa, J., Fenelon, L.E., and Hay, R.J. 1990. Evidence that the M antigen of Histoplasma capsulatum var. capsulatum is a catalase which exhibits cross-reactivity with other dimorphic fungi. J. Med. Vet. Mycol.28, 479–485.
50. Heninger, E., Hogan, L.H., Karman, J., Macvilay, S., Hill, B., Woods, J.P., and Sandor, M. 2006. Characterization of the Histoplasma capsulatum–induced granuloma. J. Immunol.177, 3303–3313.
51. Hilty, J., Smulian, A.G., and Newman, S.L. 2008. The Histoplasma capsulatum vacuolar ATPase is required for iron homeostasis, intracellular replication in macrophages and virulence in a murine model of histoplasmosis. Mol. Microbiol.70, 127–139.
52. Hilty, J., Smulian, A.G., and Newman, S.L. 2011. Histoplasma capsulatum utilizes siderophores for intracellular iron acquisition in macrophages. Med. Mycol.49, 633–642.
53. Hogan, L.H., Josvai, S., and Klein, B.S. 1995. Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J. Biol. Chem.270, 30725–30732.
54. Hogan, L.H. and Klein, B.S. 1994. Altered expression of surface a-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect. Immun.62, 3543–3546.
55. Holbrook, E.D., Edwards, J.A., Youseff, B.H., and Rappleye, C.A. 2011. Definition of the extracellular proteome of pathogenicphase Histoplasma capsulatum. J. Proteome Res.10, 1929–1943.
56. Holbrook, E.D., Smolnycki, K.A., Youseff, B.H., and Rappleye, C.A. 2013. Redundant catalases detoxify phagocyte reactive oxygen and facilitate Histoplasma capsulatum pathogenesis. Infect. Immun.81, 2334–2346.
57. Howard, D.H. 1981. Comparative sensitivity of Histoplasma capsulatum conidiospores and blastospores to oxidative antifungal systems. Infect. Immun.32, 381–387.
58. Howard, D.H. 1983. Studies on the catalase of Histoplasma capsulatum. Infect. Immun.39, 1161–1166.
59. Howard, D.H., Rafie, R., Tiwari, A., and Faull, K.F. 2000. Hydroxamate siderophores of Histoplasma capsulatum. Infect. Immun.68, 2338–2343.
60. Hwang, L., Hocking Murray, D., Bahrami, A.K., Andersson, M., Rine, J., and Sil, A. 2003. Identifying phase-specific genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray. Mol. Biol. Cell14, 2314–2326.
61. Hwang, L.H., Mayfield, J.A., RIne, J., and Sil, A. 2008. Histoplasma requires SID1, a member of an iron-regulated siderophore gene cluster, for host colonization. PLoS Pathog.4, e1000044.
62. Hwang, L.H., Seth, E., Gilmore, S.A., and Sil, A. 2012. SRE1 regulates iron-dependent and -independent pathways in the fungal pathogen Histoplasma capsulatum. Eukaryot. Cell11, 16–25.
63. Inglis, D.O., Voorhies, M., Hocking Murray, D.R., and Sil, A. 2013. Comparative transcriptomics of infectious spores from the fungal pathogen HIstoplasma capsulatum reveals a core set of transcripts that specify infectious and pathogenic states. Eukaryot. Cell12, 828–852.
64. Isaac, D.T., Berkes, C.A., English, B.C., Hocking Murray, D., Lee, Y.N., Coady, C., and Sil, A. 2015. Macrophage cell death and transcriptional response are actively triggered by the fungal virulence factor Cbp1 during H. capsulatum infection. Mol. Microbiol.98, 910–929.
65. Isaac, D.T., Coady, A., Van Prooyen, N., and Sil, A. 2013. The 3- hydroxy-methylglutaryl coenzyme A lyase HCL1 is required for macrophage colonization by human fungal pathogen Histoplasma capsulatum. Infect. Immun.81, 411–420.
66. Johnson, C.H., Klotz, M.G., York, J.L., Kruft, V., and McEwen, J.E. 2002. Redundancy, phylogeny, and differential expression of Histoplasma capsulatum catalases. Microbiology148, 1129–1142.
67. Johnson, C.H., Prigge, J.T., Warren, A.D., and McEwen, J.E. 2003. Characterization of an alternate oxidase activity of Histoplasma capsulatum. Yeast15, 381–388.
68. Keath, E.J. and Abidi, F.E. 1994. Molecular cloning and sequence analysis of yps-3, a yeast phase–specific gene in the dimorphic fungal pathogen Histoplasma capsulatum. Microbiology140, 759–767.
69. Keath, E.J., Painter, A.A., Kobayashi, G.S., and Medoff, G. 1989. Variable expression of a yeast-phase-specific gene in Histoplasma capsulatum strains differing in thermotolerance and virulence. Infect. Immun.57, 1384–1390.
70. Kemski, M.M., Stevens, B., and Rappleye, C.A. 2013. Spectrum of T-DNA integrations for insertional mutagenesis of Histoplasma capsulatum. Fungal Biol.117, 41–51.
71. Klimpel, K.R. and Goldman, W.E. 1987. Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum. Infect. Immun.55, 528–533.
72. Klimpel, K.R. and Goldman, W.E. 1988. Cell walls from avirulent variants of Histoplasma capsulatum lack a-(1,3)-glucan. Infect. Immun.56, 2997–3000.
73. Kugler, S., Young, B., Miller, V.L., and Goldman, W.E. 2000. Monitoring phase-specific gene expression in Histoplasma capsulatum with telomeric GFP fusion plasmids. Cell. Microbiol.2, 537–547.
74. Lane, T.E., Otero, G.C., Wu-Hsieh, B.A., and Howard, D.H. 1994. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect. Immun.62, 1478–1479.
75. Lane, T.E., Wu-Hsieh, B.A., and Howard, D.H. 1991. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect. Immun.59, 2274–2278.
76. Lane, T.E., Wu-Hsieh, B.A., and Howard, D.H. 1993. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect. Immun.61, 1468–1473.
77. Laskowski-Peak, M.C., Calvo, A.M., Rohrssen, J., and Smulian, A.G. 2012. VEA1 is required for cleistothecial formation and virulence in Histoplasma capsulatum. Fungal Genet. Biol.49, 838–846.
78. Luckett, K., Dummer, J.S., Miller, G., Hester, S., and Thomas, L. 2015. Histoplasmosis in patients with cell-mediated immunodeficiency: human immunodeficiency virus infection, organ transplantation, and tumor necrosis factor-a inhibition. Open Forum Infect. Dis.2, ofu116.
79. Maresca, B., Jacobson, E., Medoff, G., and Kobayashi, G. 1978. Cystine reductase in the dimorphic fungus Histoplasma capsulatum. J. Bacteriol.135, 987–992.
80. Maresca, B., Lambowitz, A.M., Kobayashi, G.S., and Medoff, G. 1979. Respiration in the yeast and mycelial phases of Histoplasma capsulatum. J. Bacteriol.138, 647–649.
81. Marion, C.L., Rappleye, C.A., Engle, J.T., and Goldman, W.E. 2006. An a-(1,4)-amylase is essential for a-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol. Microbiol.62, 970–983.
82. Medoff, J., Jacobson, E., and Medoff, G. 1981. Regulation of dimorphism in Histoplasma capsulatum by cyclic AMP. J. Bacteriol.145, 1452–1455.
83. Medoff, G., Kobayashi, G.S., Painter, A., and Travis, S. 1987. Morphogenesis and pathogenicity of Histoplasma capsulatum. Infect. Immun.55, 1355–1358.
84. Medoff, G., Maresca, B., Lambowitz, A.M., Kobayashi, G., Painter, A., Sacco, M., and Carratu, L. 1986a. Correlation between pathogenicity and termperature sensitivity in different strains of Histoplasma capsulatum. J. Clin. Invest.78, 1638–1647.
85. Medoff, G., Sacco, M., Maresca, B., Schlessinger, D., Painter, A., Kobayashi, G.S., and Carratu, L. 1986b. Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science231, 476–479.
86. Mihu, M.R. and Nosanchuk, J.D. 2012. Histoplasma virulence and host responses. Int. J. Microbiol.2012, 268123.
87. Modlin, R.L. and Bloom, B.R. 2013. TB or not TB: that is no longer the question. Sci. Transl. Med.5, 213sr6.
88. Nemecek, J.C., Wuthrich, M., and Klein, B.S. 2006. Global control of dimorphism and virulence in fungi. Science312, 583–588.
89. Newman, S.L., Gootee, L., Brunner, G., and Deepe, G.S. 1994. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J. Clin. Invest.93, 1422–1429.
90. Newman, S.L., Gootee, L., Stroobant, V., van der Goot, H., and Boelaert, J.R. 1995. Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine. Antimicrob. Agents Chemother.39, 1824–1829.
91. Newman, S.L. and Smulian, A.G. 2013. Iron uptake and virulence in Histoplasma capsulatum. Curr. Opin. Microbiol.16, 700–707.
92. Nguyen, V.Q. and Sil, A. 2008. Temperature-induced switch to the pathogenic yeast form of Histoplasma capsulatum requires Ryp1, a conserved transcriptional regulator. Proc. Nat. Acad. Sci. USA105, 4880–4885.
93. Patel, J.B., Batanghari, J.W., and Goldman, W.E. 1998. Probing the yeast phase–specific expression of the CBP1 gene of Histoplasma capsulatum. J. Bacteriol.180, 1786–1792.
94. Rappleye, C.A, Eissenberg, L.G., and Goldman, W.E. 2007. Histoplasma capsulatum a-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc. Nat. Acad. Sci. USA104, 1366–1370.
95. Rappleye, C.A., Engle, J.T., and Goldman, W.E. 2004. RNA interference in Histoplasma capsulatum demonstrates a role for a-(1,3)-glucan in virulence. Mol. Microbiol.53, 153–165.
96. Rappleye, C.A. and Goldman, W.E. 2007. Fungal stealth technology. Trends Immunol.29, 18–24.
97. Retallack, D.M., Deepe, G.S., and Woods, J.P. 2000. Applying in vivo expression technology (IVET) to the fungal pathogen Histoplasma capsulatum. Microb. Pathog.28, 169–182.
98. Retallack, D.M., Heinecke, E.L., Gibbons, R., Deepe, G.S., and Woods, J.P. 1999. The URA5 gene is necessary for Histoplasma capsulatum growth during infection of mouse and human cells. Infect. Immun.67, 624–629.
99. Rooney, P.J. and Klein, B.S. 2004. Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis. Eukaryot. Cell3, 785–794.
100. Sacco, M., Maresca, B., Kumar, B.V., Kobayashi, G.S., and Medoff, G. 1981. Temperature- and cyclic nucleotide-induced phase transitions of Histoplasma capsulatum. J. Bacteriol.146, 117–120.
101. San-Blas, G., San-Blas, E., Ormaechea, E., and Serrano, L.E. 1977a. Cell wall analysis of an adenine requiring mutant of the yeastlike form of Paracoccidiodes brasiliensis strain IVIC Pb9. Sabouraudia15, 297–303.
102. San-Blas, G., San-Blas, F., and Serrano, L.E. 1977b. Host-parasite relationships in the yeastlike form of Paracoccidiodes brasiliensis strain IVIC Pb9. Infect. Immun.15, 343–346.
103. Sebghati, T.S., Engle, J.T., and Goldman, W.E. 2000. Intracellular parasitism by Histoplasma capsulatum fungal virulence and calcium dependence. Science290, 1368–1372.
104. Sil, A. and Andrianopoulos, A. 2014. Thermally dimorphic human fungal pathogens–polyphyletic pathogens with a convergent pathogenicity trait. Cold Spring Harb. Perspect. Med.5, a019794.
105. Spitzer, E.D., Keath, E.J., Travis, S.J., Painter, A.A., Kobayashi, G.S., and Medoff, G. 1990. Temperature-sensitive variants of Histoplasma capsulatum isolated from patients with acquired immunodeficiency syndrome. J. Infect. Dis.162, 258–261.
106. Sullivan, T.D., Rooney, P.J., and Klein, B.S. 2002. Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast. Eukaryot. Cell1, 895–905.
107. Sutcliffe, M.C., Savage, A.M., and Alford, R.H. 1980. Transferrindependent growth inhibition of yeast-phase Histoplasma capsulatum by human serum and lymph. J. Infect. Dis.142, 209–219.
108. Thompson, D.S., Carlisle, P.L., and Kadosh, D. 2011. Coevolution of morphology and virulence in Candida species. Eukaryot. Cell10, 1173–1182.
109. Timmerman, M.M. and Woods, J.P. 1999. Ferric reduction is a potential iron acquisition mechanism for Histoplasma capsulatum. Infect. Immun.67, 6403–6408.
110. Timmerman, M.M. and Woods, J.P. 2001. Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum. Infect. Immun.69, 7671–7678.
111. Vignesh, K.S., Landero Figueroa, J.A., Porollo, A., Caruso, J.A., and Deepe, G.S. 2013. Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity39, 697–710.
112. Vite-Garin, T., Estrada-Barcenas, D.A., Cifuentes, J., and Taylor, M.L. 2014. The importance of molecular analyses for understanding the genetic diversity of Histoplasma capsulatum: an overview. Rev. Iberoam. Micol.31, 11–15.
113. Weaver, C.H., Sheehan, K.C.F., and Keath, E.J. 1996. Localization of a yeast phase - specific gene product to the cell wall in Histoplasma capsulatum. Infect. Immun.64, 3048–3054.
114. Webster, R.H. and Sil, A. 2008. Conserved factors Ryp2 and Ryp3 control cell morphology and infectious spore formation in the fungal pathogen Histoplasma capsulatum. Proc. Nat. Acad. Sci. USA105, 14573–14578.
115. Wheat, L.J., Chetchotisakd, P., Williams, B., Connolly, P., Shutt, K., and Hajjeh, R. 2000. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin. Infect. Dis.30, 877–881.
116. Winters, M.S., Chan, Q., Caruso, J.A., and Deepe, G.S. 2010. Metallomic analysis of macrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses. J. Infect. Dis.202, 1136–1145.
117. Wolf, J.E., Abegg, A.L., Travis, S.J., Kobayashi, G.S., and Little, J.R. 1989. Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst and antifungal activities. Infect. Immun.57, 513–519.
118. Woods, J.P. 2002. Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment. Fungal Genet. Biol.35, 81–97.
119. Woods, J.P. 2003. Knocking on the right door and making a comfortable home: Histoplasma capsulatum intracellular pathogenesis. Curr. Opin. Microbiol.6, 327–331.
120. Woods, J.P. 2005. Histoplasma hairpins herald hopefulness. Trends Microbiol.13, 88–91.
121. Woods, J.P. and Goldman, W.E. 1992. In vivo generation of linear plasmids with addition of telomeric sequences by Histoplasma capsulatum. Mol. Microbiol.6, 3603–3610.
122. Woods, J.P. and Goldman, W.E. 1993. Autonomous replication of foreign DNA in Histoplasma capsulatum: Role of native telomeric sequences. J. Bacteriol.175, 636–641.
123. Woods, J.P., Heinecke, E.L., and Goldman, W.E. 1998. Electrotransformation and expression of bacterial genes encoding hygromycin phosphotransferase and β-galactosidase in the pathogenic fungus Histoplasma capsulatum. Infect. Immun.66, 1697–1707.
124. Woods, J.P., Heinecke, E.L., Luecke, J.W., Maldonado, E., Ng, J.Z., Retallack, D.M., and Timmerman, M.M. 2001. Pathogenesis of Histoplasma capsulatum. Semin. Respir. Infect.16, 91–101.
125. Woods, J.P., Retallack, D.M., Heinecke, E.L., and Goldman, W.E. 1998. Rare homologous gene targeting in Histoplasma capsulatum: disruption of the URA5Hc gene by allelic replacement. J. Bacteriol.180, 5135–5143.
126. Worsham, P.L. and Goldman, W.E. 1988. Selection and characterization of ura5 mutants of Histoplasma capsulatum. Mol. Gen. Genet.214, 348–352.
127. Worsham, P.L. and Goldman, W.E. 1990. Development of a genetic transformation system for Histoplasma capsulatum: complementation of uracil auxotrophy. Mol. Gen. Genet.221, 358–362.
128. Wu-Hsieh, B.A., Chen, W., and Lee, H. 1998. Nitric oxide synthase expression in macrophages of Histoplasma capsulatum-infected mice is associated with splenocyte apoptosis and unresponsiveness. Infect. Immun.66, 5520–5526.
129. Youseff, B.H., Holbrook, E.D., Smolnycki, K.A., and Rappleye, C.A. 2012. Extracellular superoxide dismutase protects Histoplasma yeast cells from host-derived oxidative stress. PLoS Pathog.8, e1002713.
130. Zancope-Oliveira, R.M., Reiss, E., Lott, T.J., Mayer, L.W., and Deepe, G.S. 1999. Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect. Immun.67, 1947–1953.
131. Zarnowski, R., Cooper, K.G., Brunold, L.S., Calaycay, J., and Woods, J.P. 2008. Histoplasma capsulatum secreted ?-glutamyltransferase reduces iron by generating an efficient ferric reductant. Mol. Microbiol.70, 352–368.
132. Zarnowski, R. and Woods, J.P. 2005. Glutathione-dependent extracelluar ferric reductase activities in dimorphic zoopathogenic fungi. Microbiology151, 2233–2240.
133. Zemska, O. and Rappleye, C.A. 2012. Agrobacterium-mediated insertional mutagenesis in Histoplasma capsulatum. Methods Mol. Biol.845, 51–66.